[Federal Register Volume 66, Number 128 (Tuesday, July 3, 2001)]
[Notices]
[Page 35269]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-16683]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 5, 2000, and published in the Federal 
Register on January 10, 2001 (66 FR 2004), the National Center for 
Development of Natural Products, the University of Mississippi, 135 Coy 
Waller Complex, University, Mississippi 38677, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the controlled substances listed below:

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)............................................          I
Tetrahydrocannabinols (7370)................................          I
------------------------------------------------------------------------

    The firm plans to bulk manufacture for product development.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, Untied States Code, section 823(a) and 
determined that the registration of National Center for Development of 
Natural Products to manufacture the listed controlled substances is 
consistent with the public interest at this time. This determination 
was based on, among other things, DEA's on-site investigation of the 
National Center for Development for Natural Products. The investigation 
included inspection and testing of the applicant's qualifications and 
experience, verification of the applicant's compliance with state and 
local laws, and a review of the firm's background and history. DEA has 
further determined that the registration will be consistent with United 
States obligations under international treaties. Therefore, pursuant to 
21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.

    Dated: June 19, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-16683 Filed 7-2-01; 8:45 am]
BILLING CODE 4410-09-M